Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA, Industry Reach Agreement On Major Portions Of Generic User Fee Program

This article was originally published in The Pink Sheet Daily

Executive Summary

Pending agreement includes a one-time fee for ANDA applications in the backlog.
Advertisement

Related Content

ANDA User Fee Negotiations Finished; Backlog To Be Mostly Cleared By Year Five
GPhA's New CEO Ralph Neas Brings Health Reform Advocacy Experience
GPhA's New CEO Ralph Neas Brings Health Reform Advocacy Experience
Lilly's Field Of Dreams: "Campaign For Modern Medicines" Wants A Clean PDUFA
ANDA User Fee Agreement Expected To Be Finished in Early September
Generic Drug User Fees Will Begin With The Backlog
How "Clean" Will PDFUA V Be? Rep. Pitts Explains His Vacuuming Technique
ANDA User Fees: Negotiators Close To Agreement, But Backlog Is Sticking Point
"Mega-UFA" Is Behind Schedule; Combined User Fee Bill Will Be Difficult, But Still Expected
"Mega-UFA" Is Behind Schedule; Combined User Fee Bill Will Be Difficult, But Still Expected

Topics

Advertisement
UsernamePublicRestriction

Register

PS072624

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel